Market Tracker

09/02 6:05pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

16.14
Data as of Sep 02
 -0.17 / -1.04%
Today’s Change
8.57
Today|||52-Week Range
20.29
+72.81%
Year-to-Date

Today’s Trading

Previous close16.31
Today’s open16.54
Day’s range16.04 - 16.54
Volume547,263
Average volume (3 months)521,097
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-13.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book9.12

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...-1.27-3.60%
KPTIKaryopharm Therapeut...+0.60+1.67%
CBPOChina Biologic Produ...+0.43+0.81%
EPZMEpizyme Inc-1.47-4.26%
Data as of 3:59pm ET, 09/02/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts